NCT06065228 Therapeutic Endpoint in Pediatric IBD Conditions
| NCT ID | NCT06065228 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's National Research Institute |
| Condition | Inflammatory Bowel Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-11-27 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2023-11-27 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically subtypes Crohn's disease (CD) and ulcerative colitis (UC). The novel medical device evaluates the patient's sensory response to each of the three sensory nerve fiber types. Data from the device provides an assessment of disease activity and a more precise approach to treatment.
Eligibility Criteria
Inclusion Criteria: * Male or female ≥ 6 years of age at screening. * Documentation of an IBD diagnosis as evidenced by history Exclusion Criteria: * Documented history of eye disease precluding pupillometry * Patients who are unwilling or unable to participate due to developmental delays or ongoing psychological diagnoses.
Frequently Asked Questions
Who can join the NCT06065228 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 21 Years, studying Inflammatory Bowel Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06065228 currently recruiting?
Yes, NCT06065228 is actively recruiting participants. Visit ClinicalTrials.gov or contact Children's National Research Institute to inquire about joining.
Where is the NCT06065228 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT06065228 clinical trial?
NCT06065228 is sponsored by Children's National Research Institute. The trial plans to enroll 60 participants.